Drug discount agreements from 01.07.2025 for various active ingredients under an open-house procedure
Original notice title
Germany – Pharmaceutical products – Arzneimittel-Rabattverträge ab 01.07.2025 zu diversen Wirkstoffen im Rahmen eines Open-House-Verfahrens
Opportunity Score
Why this score?
Opportunity
30 / 100
Complexity
20 / 100
Risk factors
The buyer reserves the right to conclude exclusive contracts during the term, which will suspend these open-house agree...
No guaranteed purchase volumes; actual revenue depends on prescriptions and market share.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 1 lot
- Duration until Jun 2027
- Provide drug discount agreements for the listed active ingredients and combinations.
- Contract duration up to 24 months from earliest start date 01.07.2025.
Show full summary
The AOK NordWest offers drug discount agreements (Rabattverträge) under §130a Abs. 8 SGB V for multiple active ingredients via an open-house procedure. This is not a public procurement under EU directives but is published for transparency. Qualified pharmaceutical companies can join at any time until the deadline. Contracts start no earlier than 01.07.2025, with a maximum duration of 24 months. No exclusivity is granted; future exclusive contracts may suspend these agreements.
Risks
The buyer reserves the right to conclude exclusive contracts during the term, which will suspend these open-house agree...
No guaranteed purchase volumes; actual revenue depends on prescriptions and market share.
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a pharmaceutical company as defined in §4 Abs. 18 AMG.
- Must remain a pharmaceutical company for the entire contract duration.
Administrative
- Submit request via email to [email protected].
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Location
Dortmund, DEU
Website
Identifier
DE124159739
Activity
Health
Lots (1)
LOT-0001
Drug discount agreements from 01.07.2025 for various active ingredients under an open-house procedure
Open-house procedure for drug discount agreements on multiple active ingredients (Amifampridin, Axitinib, Clindamycin & Benzoylperoxid, Fluorouracil Kombinationen, Folsäure, Imiquimod, Lamivudin & Tenofovirdisoproxil & Doravirin, Lapatinib, Macrogol, Maraviroc, Mesalazin, Peginterferon alfa-2a, Pegvisomant, Pimecrolimus, Raltegravir, Sevelamerhydrochlorid, Xylometazolin). Uniform terms and conditions. No exclusivity. Continuous accession possible.
Location
Duration
Category
Award Criteria
Deadline
Award details
Unter Vorgabe einheitlicher Vertragskonditionen sowie eines einheitlichen Zugangsverfahrens wird allen geeigneten und interessierten pharmazeutischen Unternehmen oder Gemeinschaften pharmazeutischer Unternehmen der Abschluss von Rabattverträgen nach § 130a Abs. 8 SGB V über die genannten Wirkstoffe/Wirkstoffkombinationen angeboten. Der früheste Vertragsbeginn ist der 01.07.2025. Davon ausgehend beträgt die Vertragslaufzeit maximal 24 Monate.
Value note
Show original TED data
Original lot title
Arzneimittel-Rabattverträge ab 01.07.2025 zu diversen Wirkstoffen im Rahmen eines Open-House-Verfahrens
Original TED description
Unter Vorgabe einheitlicher Vertragskonditionen sowie eines einheitlichen Zugangsverfahrens wird allen geeigneten und interessierten pharmazeutischen Unternehmen oder Gemeinschaften pharmazeutischer Unternehmen der Abschluss von Rabattverträgen nach § 130a Abs. 8 SGB V über die genannten Wirkstoffe/Wirkstoffkombinationen angeboten. Der früheste Vertragsbeginn ist der 01.07.2025. Davon ausgehend beträgt die Vertragslaufzeit maximal 24 Monate.
Procurement Details
- Publication date
- 12 May 2025
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 306881-2025
Documents (1)
Similar tenders
Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)
Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
30 / 100
Complexity
20 / 100
Risk factors
The buyer reserves the right to conclude exclusive contracts during the term, which will suspend these open-house agree...
No guaranteed purchase volumes; actual revenue depends on prescriptions and market share.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications